Loading...
  • Anal Cancer
  • This randomized phase II trial studies how well cisplatin and fluorouracil work compared with carboplatin and paclitaxel in treating patients with anal cancer that cannot be removed by sur. (bioportfolio.com)
  • Gynecologic Cancers
  • In this article, clinical indications and common techniques for radiation therapy in the management of common gynecologic cancers are described. (medscape.com)
  • Good routine care and patient education provide the most useful information for detecting recurrence of gynecologic cancers, according to new recommendations for post-treatment surveillance. (cancer.org)
  • Coordination of care among clinicians involved in post-treatment surveillance plays a key role in maintaining the continuum of follow-up for survivors of gynecologic cancers, as described in an article published online in the American Journal of Obstetrics & Gynecology. (cancer.org)
  • Gynecologic cancers account for 10% of all new cancers in women but 20% of all female cancer survivors, currently estimated at 10 million. (cancer.org)
  • Findings
  • Accordingly, our findings support the recommendation to perform LS screening in all primary, synchronous, and metachronous intestinal and endometrial cancers if a previous tumor screened intact. (osu.edu)
  • Staging guidelines from the International Federation of Gynecology and Obstetrics (FIGO) and the American Joint Committee on Cancer (AJCC) are based on surgical findings. (medscape.com)
  • newly diagnosed
  • This project will conduct a prospective, longitudinal, observational cohort study to assess the onset and incidence of lymphoedema, as well as investigate factors associated with its development among women newly diagnosed with gynaecological cancers in 2008 to 2011. (clinicaltrials.gov)
  • In 2006 the American Cancer Society (ACS) reported that 564,830 Americans died of cancer and that twice that number were newly diagnosed with one form or another of the disease. (thefreedictionary.com)
  • Recurrence
  • Point out that this report indicates that there is very little evidence that either routine cytologic procedures or imaging are sufficiently useful to detect ovarian and endometrial cancer recurrence and alter response rates to salvage therapy. (cancer.org)
  • Each tumor marker has a variable profile of usefulness for screening, determining diagnosis and prognosis, assessing response to therapy, and monitoring for cancer recurrence. (blogspot.com)
  • tumor markers
  • Participants may have samples of blood, tissue, or body fluids (such as ascites, pleural fluid or urine), or any combination of the aforementioned samples obtained to develop tumor markers to detect early stage or recurrent ovarian cancer. (clinicaltrials.gov)
  • In the future, if any of the experimental tumor markers are found to be effective in detecting early stage ovarian cancer, and the patient's result is abnormal, the patient and physician will be notified. (clinicaltrials.gov)
  • Several other tumor markers (such as the CA 125 test for ovarian cancer) are used only after a diagnosis has already been made. (tabers.com)
  • From this point of view, the use of tumor markers that consist of carbohydrate antigens, such as CA-125, in addition to diagnostic imaging are useful in the diagnosis of ovarian cancer. (blogspot.com)
  • At present, no useful tumor markers exist for endometrial cancer that exhibit both high sensitivity and specificity, although CA-125 is often used in clinical practice. (blogspot.com)
  • disorders
  • Methods of enhancing an immune response by administration of an IAP inhibitor, methods of treating or preventing cancer, methods of treating or preventing infections, methods of treating autoimmune disorders, and methods of potentiating cytokine or antibody production are also provided. (patentsencyclopedia.com)
  • The assays and kits described herein are applicable for the identification, diagnosing, and monitoring of disorders including, but not limited to cancer, developmental and degenerative disease, neurological disorders, and stem cell disorders. (patentsencyclopedia.com)